ATE284708T1 - T-zellimpfung zur behandlung von multiple sclerosis - Google Patents

T-zellimpfung zur behandlung von multiple sclerosis

Info

Publication number
ATE284708T1
ATE284708T1 AT98949378T AT98949378T ATE284708T1 AT E284708 T1 ATE284708 T1 AT E284708T1 AT 98949378 T AT98949378 T AT 98949378T AT 98949378 T AT98949378 T AT 98949378T AT E284708 T1 ATE284708 T1 AT E284708T1
Authority
AT
Austria
Prior art keywords
treatment
multiple sclerosis
cells
disclosed
methods
Prior art date
Application number
AT98949378T
Other languages
English (en)
Inventor
Leslie P Weiner
Jorge D Correale
Original Assignee
Univ Southern California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26738869&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE284708(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Southern California filed Critical Univ Southern California
Application granted granted Critical
Publication of ATE284708T1 publication Critical patent/ATE284708T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT98949378T 1997-09-19 1998-09-18 T-zellimpfung zur behandlung von multiple sclerosis ATE284708T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5953497P 1997-09-19 1997-09-19
US09/156,509 US20020009448A1 (en) 1997-09-19 1998-09-17 T-cell vaccination for the treatment of multiple sclerosis
PCT/US1998/019572 WO1999013904A1 (en) 1997-09-19 1998-09-18 T-cell vaccination for the treatment of multiple sclerosis

Publications (1)

Publication Number Publication Date
ATE284708T1 true ATE284708T1 (de) 2005-01-15

Family

ID=26738869

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98949378T ATE284708T1 (de) 1997-09-19 1998-09-18 T-zellimpfung zur behandlung von multiple sclerosis

Country Status (8)

Country Link
US (2) US20020009448A1 (de)
EP (1) EP1015025B1 (de)
AT (1) ATE284708T1 (de)
AU (1) AU755884B2 (de)
CA (1) CA2304373A1 (de)
DE (1) DE69828179D1 (de)
NO (1) NO321237B1 (de)
WO (1) WO1999013904A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7906153B2 (en) * 1998-04-08 2011-03-15 Theta Biomedical Consulting & Development Co., Inc. Anti-inflammatory compositions for treating multiple sclerosis
US20050220908A1 (en) * 2004-03-30 2005-10-06 Theoharides Theoharis C Anti-inflammatory compositions for multiple sclerosis
US6541608B1 (en) * 1999-02-23 2003-04-01 Baylor College Of Medicine T cell receptor Vβ-Dβ-Jβ sequence and methods for its detection
US7541184B2 (en) * 2000-02-24 2009-06-02 Invitrogen Corporation Activation and expansion of cells
US6894033B2 (en) 2001-06-11 2005-05-17 Transition Therapeutics Inc. Combination therapies using vitamin B12 and therapeutic agents for treatment of viral, proliferative and inflammatory diseases
US7658926B2 (en) * 2001-09-14 2010-02-09 Opexa Pharmaceuticals, Inc. Autologous T-cell vaccines materials and methods
US20050084967A1 (en) * 2002-06-28 2005-04-21 Xcyte Therapies, Inc. Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
US20040175373A1 (en) * 2002-06-28 2004-09-09 Xcyte Therapies, Inc. Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
KR100795840B1 (ko) * 2002-08-08 2008-01-17 베일러 칼리지 오브 메디신 Ｔ세포의 분리 및 식별
US20060204495A1 (en) 2002-12-31 2006-09-14 Zang Jingwu Z Isolation and identification of cross-reactive t cells
US20100003228A1 (en) * 2006-05-05 2010-01-07 Willimas Jim C T-cell vaccine
ES2552678T3 (es) * 2008-06-30 2015-12-01 Universitätsklinikum Heidelberg Células sanguíneas inmunosupresoras y métodos de producir las mismas
AU2017271122B2 (en) 2016-05-25 2023-10-26 The Council Of The Queensland Institute Of Medical Research Methods of immunotherapy
BR112019014406A2 (pt) * 2017-01-20 2020-04-28 Atara Biotherapeutics Inc métodos de tratar esclerose múltipla usando células t autólogas

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114844A (en) * 1989-03-14 1992-05-19 Yeda Research And Development Co., Ltd. Diagnosis and treatment of insulin dependent diabetes mellitus
IL165071A (en) * 1990-03-30 2008-06-05 Autoimmune Inc A peptide with the ability to stimulate a subset of T cells from multiple sclerosis patients
US5849886A (en) * 1996-07-10 1998-12-15 Oy Aboatech Ab Extraction of myelin basic protein
US7658926B2 (en) * 2001-09-14 2010-02-09 Opexa Pharmaceuticals, Inc. Autologous T-cell vaccines materials and methods

Also Published As

Publication number Publication date
AU9571398A (en) 1999-04-05
NO20001421L (no) 2000-05-19
AU755884B2 (en) 2003-01-02
DE69828179D1 (de) 2005-01-20
US20040156860A1 (en) 2004-08-12
NO20001421D0 (no) 2000-03-17
EP1015025B1 (de) 2004-12-15
US20020009448A1 (en) 2002-01-24
EP1015025A1 (de) 2000-07-05
WO1999013904A1 (en) 1999-03-25
CA2304373A1 (en) 1999-03-25
NO321237B1 (no) 2006-04-10

Similar Documents

Publication Publication Date Title
ATE284708T1 (de) T-zellimpfung zur behandlung von multiple sclerosis
ATE230417T1 (de) Peptid-immunogene zur schutzimpfung gegen und behandlung von allergien
DE69133516D1 (de) Behandlung von autoimmunkrankheiten durch orale verabreichung von autoantigenen
ATE369380T1 (de) Impfstoff zur verhütung und behanldung von alzheimer-demenz und von amyloid-bezogenen krankheiten
DE69636487D1 (de) Zusammensetzungen zur Immuntherapie und Diagnose von Tuberculosis
MXPA02005576A (es) Vacuna para la prevencion y tratamiento de la enfermedad de alzheimer y otras enfermedades relacionadas con amiloides.
DK1062341T3 (da) Muterede rekombinante allergener
AR245778A1 (es) Secuencia de nucleotido que codifica una proteina de membrana exterior de neisseria meningitis y uso de dicha proteina en preparaciones de vacuna
NO307968B1 (no) Pyrazolo- og pyrrolopyridiner og farmasøytisk blanding derav
EA200000608A1 (ru) Предотвращение и лечение амилоидогенного заболевания
DE69521521D1 (de) Mono- oder polyfunktionelle konjugate von polylysine
DK442788D0 (da) Fremgangsmaade og praeparat til behandling af non-ige-medierede lidelser
DE69032816T2 (de) Verwendung von oncostatin m zur suppression von mhc antigenen
GB9014950D0 (en) Ehv-4 glycoprotein vaccine
HUP0004831A2 (hu) Természetes allergének tolerogén fragmensei
PT907737E (pt) Muteina da il-6
HUP0003511A2 (hu) Hepatitisz-B-vírus polipeptidek

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties